From : January 1, 2004 To : June 30, 2004 NBF Report Jan ...
Welcome to NBF
Transcript of Welcome to NBF
![Page 1: Welcome to NBF](https://reader031.fdocuments.net/reader031/viewer/2022012413/616d151b944e992c386d5972/html5/thumbnails/1.jpg)
Welcome to NBF
A presentation by Dr.-Ing. Panit Kitsubun
![Page 2: Welcome to NBF](https://reader031.fdocuments.net/reader031/viewer/2022012413/616d151b944e992c386d5972/html5/thumbnails/2.jpg)
EXC
MeA&MeTSOA+D
SBT
PIP1,2 NBF
CSSCSport Complex
Dormitory
Food Center
Media Art & Media
Technology Programs:
MeA&MeT
School of Bioresources
&Technology: SBT
School of
Architecture &
Design: SOA+D
National Biopharmaceutical Facility: NBF
Bioprocess Research & Innovation Building: BRI
R&D & Pilot Plant: EXC & PIP1,2
CES Solar Cells Testing Center: CSSC
2
![Page 3: Welcome to NBF](https://reader031.fdocuments.net/reader031/viewer/2022012413/616d151b944e992c386d5972/html5/thumbnails/3.jpg)
-3-
OUR TEAMOUR TEAM
� Multidisciplinary team: scientists, engineers
( KMUTT, BIOTEC, and others)
- Research and Technical staff 141:
� 60 Ph.D., 71 M.Sc., 10 B.Sc.
- Supporting staff 93:
� 7 M.Sc., 71 B.Sc., Others 15
� Attached students, science, engineering
- 277 (60 Ph.D. & 207 M.Sc.)
BEC/BIOTEC: 20
Ph.D. 13, M.Sc.7
ECoWaste/BIOTEC: 7
Ph.D. 6, M.Sc.1
(Ph.D.: 25, MS: 71)
![Page 4: Welcome to NBF](https://reader031.fdocuments.net/reader031/viewer/2022012413/616d151b944e992c386d5972/html5/thumbnails/4.jpg)
Chemist
Chemical structure
Bioinformaticians
Chemical engineer
Metabolic engineering
Molecular biologist
Gene manipulation
Process engineer
Fermentation
Biologist,
MicrobiologistPharmacist
4
![Page 5: Welcome to NBF](https://reader031.fdocuments.net/reader031/viewer/2022012413/616d151b944e992c386d5972/html5/thumbnails/5.jpg)
cGMP
Physiological study
Strain selection/Strain engineering Scale-up
Computurizedmonitoring
Downstreamprocessing
Pilot scale and PrecommercialPilot scale and Precommercial
600 L600 L 5000 L5000 L
1500 L1500 L
Process optimization viaSystems biology
/Modeling/Simulation
50 L50 L
Ethanol Pilot Plant Biopharmaceuticals
Pilot Plant
Bioprocess Technology for 3F1P
Submerged Fermentation Pilot Plant
Solid state Fermentation Pilot Plant
Photobioreactor
+ Food Technology & Engineering
500 L500 L
5
![Page 6: Welcome to NBF](https://reader031.fdocuments.net/reader031/viewer/2022012413/616d151b944e992c386d5972/html5/thumbnails/6.jpg)
� Approx. 15% of worldwide pharmaceutical market
� 15% annual growth (total market at 5%)
Source: IMS health, Newport Premium TM for Generics, TR research6
![Page 7: Welcome to NBF](https://reader031.fdocuments.net/reader031/viewer/2022012413/616d151b944e992c386d5972/html5/thumbnails/7.jpg)
ITEMValue (Million USD)
2005 2006
EPOETIN ALFA 7.1 9.9
VACCINE, RABIES 5.6 6.9
INSULIN HUMAN ISOPHANE
6.7 7.2
MIXED INSULIN (HUMAN) 3.7 6.0
Total 23.1 30.0
Estimated value of drugs used in Thai hospitals in 2005 and 2006(All imported)
Increase of approx. 30% over just one year! 7
![Page 8: Welcome to NBF](https://reader031.fdocuments.net/reader031/viewer/2022012413/616d151b944e992c386d5972/html5/thumbnails/8.jpg)
Source: IMS health Asia 8
![Page 9: Welcome to NBF](https://reader031.fdocuments.net/reader031/viewer/2022012413/616d151b944e992c386d5972/html5/thumbnails/9.jpg)
Source: Thailand National Cancer Institute and Thailand Rheumatic Society (2008)9
![Page 10: Welcome to NBF](https://reader031.fdocuments.net/reader031/viewer/2022012413/616d151b944e992c386d5972/html5/thumbnails/10.jpg)
10
� Biologics (except vaccines) are still 100% imported
� worth approx. $1 bn in 2013.
� Health insurance issues:� State employees enjoy full coverage
� Public sectors
� 30 Baht Scheme (Universal Coverage Program)
� Government encourages use of generics.
� Extensive R&D in tropical issues & generic drugs
� No capacity for translational research (production for clinical trials)
![Page 11: Welcome to NBF](https://reader031.fdocuments.net/reader031/viewer/2022012413/616d151b944e992c386d5972/html5/thumbnails/11.jpg)
Drugs Commercial names
Epoetin beta RECORMON
Leuprorelin acetate ENANTONE L.P.
Calcitonin salmon MIACALCIC
InsulinNOVORAPID PENFILL
HUMALOG MIX 25
Hepatitis B Vaccine HEPAVAX-GENE
Alteplase ACTILYSEFilgrastim FILGEN
Lenograstim GRANOCYTE INJECTION
Clostidium Botulinum Toxin Type A
DYSPORT11
![Page 12: Welcome to NBF](https://reader031.fdocuments.net/reader031/viewer/2022012413/616d151b944e992c386d5972/html5/thumbnails/12.jpg)
� Thai Red Cross
� BCG vaccine
� Plasma derived products
� GPO
� JE vaccine (mouse based)
� Greater Pharma
� House Dust Mite vaccine
� Department of Livestock Development
� Avian Influenza vaccine, HFMD vaccine, etc.12
![Page 13: Welcome to NBF](https://reader031.fdocuments.net/reader031/viewer/2022012413/616d151b944e992c386d5972/html5/thumbnails/13.jpg)
CROs = Contract research organizations or Clinical research organizationsCMOs = Contract manufacturing organizationsCSOs = Contract service organizations
Drugdiscovery
Pre-clinical
GMP compliant
Process development
Clinical Phase I,II&III
Large scale manufacturing
Dosageformulation
& packaging
Marketing & distribution
Large pharmaceutical company
Research unit
CSOs
Small pharmaceutical companyCROs Hospital
CROs
CMO
Thailand’s capability
13
![Page 14: Welcome to NBF](https://reader031.fdocuments.net/reader031/viewer/2022012413/616d151b944e992c386d5972/html5/thumbnails/14.jpg)
� A-BIO (Singapore, ceased operations)
� Inno Biologics (Malaysia, cell culture)
� Alpha Biologics (Malaysia, cell culture)
� LONZA (Singapore, large scale cell culture and microbial fermentation)
� Only few CMOs offering manufacturing services for smaller batches
14
![Page 15: Welcome to NBF](https://reader031.fdocuments.net/reader031/viewer/2022012413/616d151b944e992c386d5972/html5/thumbnails/15.jpg)
15
![Page 16: Welcome to NBF](https://reader031.fdocuments.net/reader031/viewer/2022012413/616d151b944e992c386d5972/html5/thumbnails/16.jpg)
� To be Thailand’s first research organization to produce clinical grade materials according to international standards (cGMP, USFDA, EMEA)
� To give services in process development ranging from laboratory to pilot scale.
� To give training and consultancy in specific technical and regulatory issues
16
![Page 17: Welcome to NBF](https://reader031.fdocuments.net/reader031/viewer/2022012413/616d151b944e992c386d5972/html5/thumbnails/17.jpg)
Funding from:-Royal Thai Government-KMUTT-BIOTEC
Research funding from-TCELS-CPMO-Private sector
17
![Page 18: Welcome to NBF](https://reader031.fdocuments.net/reader031/viewer/2022012413/616d151b944e992c386d5972/html5/thumbnails/18.jpg)
� Thailand’s first CMO
� Thailand’s first producer of recombinant drugs for clinical trials
� Contract Research And Manufacturing Services (CRAMS)
� >50 FTE scientists and engineers
18
![Page 19: Welcome to NBF](https://reader031.fdocuments.net/reader031/viewer/2022012413/616d151b944e992c386d5972/html5/thumbnails/19.jpg)
� National facility & national agenda
� GMP standard (PIC/S, EMEA and USFDA)
� Qualified personnels
� Adequate and efficient public relations
� Financial self-sustainability in the long run
� Commitments from stake-holders (KMUTT, BIOTEC/NSTDA and MoPH)
19
![Page 20: Welcome to NBF](https://reader031.fdocuments.net/reader031/viewer/2022012413/616d151b944e992c386d5972/html5/thumbnails/20.jpg)
Government
cGMP facilityKMUTT/NSTDA/
Others
Biopharma
Industry/
researchers
resourcesProduct/IP
฿฿฿
฿฿฿
� Self-sustained organization, where
profit is not the primary goal
� Venture philanthropy concept
� Investment by the government
including some seed funding
� Widely utilized in healthcare/medical
research Translational research
20
![Page 21: Welcome to NBF](https://reader031.fdocuments.net/reader031/viewer/2022012413/616d151b944e992c386d5972/html5/thumbnails/21.jpg)
21
![Page 22: Welcome to NBF](https://reader031.fdocuments.net/reader031/viewer/2022012413/616d151b944e992c386d5972/html5/thumbnails/22.jpg)
� Total utilizable area : 10�000 sqm
� Unit I-Microbial Bioprocess
� Area: 600 sqm
� Unit II-Cell Culture Bioprocess � Area: 800 sqm
� Automatic vial filling
22
![Page 23: Welcome to NBF](https://reader031.fdocuments.net/reader031/viewer/2022012413/616d151b944e992c386d5972/html5/thumbnails/23.jpg)
• Bioreactors– Up to 500 L working volume
– CIP & SIP capable
– Online monitoring of process
parameters
• Centrifuges• Continuous (Alfalaval)
• Floor-type
23
![Page 24: Welcome to NBF](https://reader031.fdocuments.net/reader031/viewer/2022012413/616d151b944e992c386d5972/html5/thumbnails/24.jpg)
� Chromatography techniques
� Ion exchanger
� Affinity
� Hydrophobic interaction
� Gel filtration
24
![Page 25: Welcome to NBF](https://reader031.fdocuments.net/reader031/viewer/2022012413/616d151b944e992c386d5972/html5/thumbnails/25.jpg)
� Tangential Flow Filtration Concentration
� Diafiltration
� Clarification
� Depyrogenation
� Desalting
� Membrane
� Ultrafiltration, max. membrane area 5 sqm.
� Microfiltration, Hollow fiber
25
![Page 26: Welcome to NBF](https://reader031.fdocuments.net/reader031/viewer/2022012413/616d151b944e992c386d5972/html5/thumbnails/26.jpg)
� Fully equipped cleanrooms grade B, C and D
� Cell culture unit capacity up to 600L
� Downstream unit with microfiltration, ultrafiltration and chromatography
� Fully automatic filling line for vials (6000 vials/h)
� Freeze drying capability 26
![Page 27: Welcome to NBF](https://reader031.fdocuments.net/reader031/viewer/2022012413/616d151b944e992c386d5972/html5/thumbnails/27.jpg)
� Documentation
Quality Manual (QM)
Site Master File (SMF)
Validation Master Plan (VMP)
Standard operating procedure (SOP)
Batch release, record
� Raw material handling
� Environmental monitoring
27
![Page 28: Welcome to NBF](https://reader031.fdocuments.net/reader031/viewer/2022012413/616d151b944e992c386d5972/html5/thumbnails/28.jpg)
� Chemical QC LabGC-TOF-MSHPLCLCMSTOC AnalyzerWet Chemical AnalyzerAir borne particle counter
� Biology QC LabMicrobial Air Sampler
� Sterility Test� Stability Test� ELISA � Animal testing to be outsourced
28
![Page 29: Welcome to NBF](https://reader031.fdocuments.net/reader031/viewer/2022012413/616d151b944e992c386d5972/html5/thumbnails/29.jpg)
29
![Page 30: Welcome to NBF](https://reader031.fdocuments.net/reader031/viewer/2022012413/616d151b944e992c386d5972/html5/thumbnails/30.jpg)
� Soft opening� In 2012
� Official Opening� March 24, 2014
� Manufacturing License (2014)� Microbial production of API
� Cell Culture production of API
� Aseptic Filling
� Repackaging
30
![Page 31: Welcome to NBF](https://reader031.fdocuments.net/reader031/viewer/2022012413/616d151b944e992c386d5972/html5/thumbnails/31.jpg)
Contact Us:
National Biopharmaceutical Facility
King Mongkut’s University of Technology Thonburi
49 Soi Thian Thale 25, Bang Khun Thian Chai Thale Road,
Tha Kham, Bang Khun Thian, Bangkok 10150, Thailand
Tel: +66 24707495
Fax: +66 24523455
E-mail: [email protected]
Website: http://www.nbf.kmutt.ac.th
31